[Study protocol of the monocentric prospective randomized placebo-controlled double-blind phase  II study to explore the protective effects of the ginkgo biloba extract EGb 761® from temporary noise-induced hearing loss].

CONCLUSION: This summary of the verification study protocol highlights the complexity of diligent and precise planning according to the European Medicines Agency criteria for controlled trials (EudraCT). Key points are the intervention rationale, definitions of in- and exclusion criteria, estimation of subject numbers, and examination method setting in terms of optimum endpoint description. PMID: 31915883 [PubMed - as supplied by publisher]
Source: HNO - Category: ENT & OMF Tags: HNO Source Type: research